ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Serum Prostate-Specific Antigen Concentrations in Polycystic Ovary Syndrome: A Comparative Analysis of Hirsute and Non-Hirsute Phenotypes.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePolycystic ovary syndrome (PCOS), affecting 5-10% of reproductive-aged women, is marked by anovulation and hyperandrogenism. Prostate-specific antigen (PSA), traditionally a prostate cancer biomarker, has also been detected in female tissues and proposed as a marker of androgen activity. This study examined whether serum total and free PSA differ between hirsute and non-hirsute PCOS phenotypes, hypothesizing higher levels in the hirsute group.
methodsIn this prospective case-control study, 90 women with PCOS diagnosed by the 2003 Rotterdam ESHRE/ASRM criteria were enrolled between May 2022 and January 2023. Participants were stratified into hirsute and non-hirsute groups using the modified Ferriman-Gallwey score. Demographic, clinical, and reproductive data were recorded, and venous blood samples collected on cycle days 2-3 were analyzed for PSA, androgens, and metabolic parameters. Insulin resistance was assessed using homeostatic model assessment of insulin resistance (HOMA-IR).
resultsAge did not differ between groups, but body mass index (BMI) (p = 0.044), acne prevalence (p = 0.032), and free testosterone (p = 0.014) were significantly higher in hirsute women. Amenorrhea and oligomenorrhea were more frequent in the non-hirsute group (p = 0.012). Ovarian morphology, alopecia, and PSA levels showed no significant differences between groups (all p > 0.05). However, Spearman rank correlation analysis revealed significant positive correlations between PSA and Ferriman-Gallwey score (r
conclusionsHirsute phenotypes demonstrated clustered hyperandrogenic features, including higher free testosterone, BMI, and acne prevalence. Although PSA levels did not differ between phenotypic groups, the significant positive correlations with hirsutism score and metabolic parameters suggest that PSA may reflect androgenic-metabolic activity in PCOS, underscoring the heterogeneity of the syndrome and the need for comprehensive phenotypic assessment.
Indexed as
Identifiers
42736521What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.